stockrowHaleon PLC Sponsored ADR
HLN Healthcare Drug Manufacturers Specialty & Generic
Haleon PLC Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $14.5 billion, up 1.33% from fiscal 2024.
Follow HLN
Alert me
Haleon PLC Sponsored ADR (HLN) Price to free cash flow
As of 5 November 2026, Haleon PLC Sponsored ADR (HLN) trades at a price to free cash flow of 9.2×. Over the past ten years it has ranged from 0.0× (June 2024) to 11.2× (June 2025); the current reading is higher than 64% of that period. That is below the Drug Manufacturers Specialty & Generic industry median of 16.3× and below the Healthcare sector median of 21.1×.
Price to free cash flow, daily
Embed this chart
Annual newest first
| Period | Price to free cash flow | Change |
|---|---|---|
| FY2025 | 9.0× | (4.02%) |
| FY2024 | 9.4× | — |
| FY2023 | 0.0× | — |
| FY2022 | 0.0× | — |
| FY2021 | 0.0× | — |
| FY2020 | 0.0× | — |
| FY2019 | 0.0× | — |
Quarterly newest first
| Period | Price to free cash flow | Change |
|---|---|---|
| Sep 2024 | 10.4× | — |
| Mar 2024 | 0.0× | — |
| Sep 2023 | 0.0× | — |
| Jun 2023 | 0.0× | — |
| 1 more quarters | Free account |
Against its own ten years
Price to free cash flow against peers
| Company | Price to free cash flow |
|---|---|
| TAK Takeda Pharmaceutical Co. compare | 8.4× |
| HLN Haleon PLC Sponsored ADR | 9.2× |
| VTRS Viatris Inc. compare | 10.7× |
| ZTS Zoetis Inc. compare | 14.7× |
| NBIX Neurocrine Biosciences, Inc. compare | 15.7× |
| UTHR United Therapeutics Corporation compare | 28.0× |
| ELAN Elanco Animal Health Incorporated compare | 33.2× |
| TEVA Teva Pharmaceutical Industries Ltd. compare | 36.6× |
| RDY Dr. Reddy's Laboratories Ltd compare | 126× |
| Drug Manufacturers Specialty & Generic industry median | 16.3× |
| Healthcare sector median | 21.1× |
| Market median | 14.1× |
What Price to free cash flow is
Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.
Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))
More on HLN
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Altman Z-score
- Beneish M-score
- The full statement